Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 42.86 -0.65% -0.28
PTCT closed down 0.65 percent on Friday, September 13, 2019, on 72 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical PTCT trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish -0.65%
50 DMA Resistance Bearish -0.65%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.65%
Spinning Top Other -0.65%
Outside Day Range Expansion -0.65%
20 DMA Resistance Bearish -2.66%
Stochastic Buy Signal Bullish -2.66%

Older signals for PTCT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases New Jersey Gene Expression Neurological Disorders Astrazeneca Muscular Dystrophy Celgene Spinal Muscular Atrophy Dystrophy Neurodegenerative Disorders Neuromuscular Disorders
Is PTCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.99
52 Week Low 27.53
Average Volume 361,288
200-Day Moving Average 38.3569
50-Day Moving Average 44.6038
20-Day Moving Average 44.118
10-Day Moving Average 43.221
Average True Range 1.7846
ADX 12.74
+DI 17.984
-DI 18.0156
Chandelier Exit (Long, 3 ATRs ) 41.5162
Chandelier Exit (Short, 3 ATRs ) 46.8838
Upper Bollinger Band 46.6454
Lower Bollinger Band 41.5906
Percent B (%b) 0.25
BandWidth 11.457455
MACD Line -0.553
MACD Signal Line -0.4237
MACD Histogram -0.1293
Fundamentals Value
Market Cap 1.77 Billion
Num Shares 41.4 Million
EPS -3.05
Price-to-Earnings (P/E) Ratio -14.05
Price-to-Sales 5.48
Price-to-Book 3.95
PEG Ratio 0.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.39
Resistance 3 (R3) 44.43 43.96 44.14
Resistance 2 (R2) 43.96 43.57 43.94 44.05
Resistance 1 (R1) 43.41 43.33 43.18 43.37 43.96
Pivot Point 42.94 42.94 42.82 42.92 42.94
Support 1 (S1) 42.39 42.55 42.16 42.35 41.76
Support 2 (S2) 41.92 42.31 41.90 41.67
Support 3 (S3) 41.37 41.92 41.59
Support 4 (S4) 41.33